Transcriptomic analysis of genetically defined autism candidate genes reveals common mechanisms of action

Molecular Autism

Volumn 4, Issue 1, 2013, Pages

  Lanz, Thomas A ^a   Guilmette, Edward ^a   Gosink, Mark M ^a   Fischer, James E ^a   Fitzgerald, Lawrence W ^a,b   Stephenson, Diane T ^a,c   Pletcher, Mathew T ^a  

^a PFIZER INC   (United States)

^b LW Fitzgerald Consulting   (United States)

^c CRITICAL PATH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; METHYL CPG BINDING PROTEIN 2; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; MYOCYTE ENHANCER FACTOR 2D; NEUROLIGIN; NEUROLIGIN 1; NEUROLIGIN 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SCAFFOLD PROTEIN; SH3 AND MULTIPLE ANKYRIN REPEAT DOMAIN 3 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTISM; CELL CULTURE; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC ANALYSIS; GENETIC DISORDER; LENTIVIRINAE; LONG TERM POTENTIATION; MOUSE; NERVE CELL CULTURE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SYNAPTIC POTENTIAL; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; VIRUS INFECTION;

LENTIVIRUS;

EID: 84887514274     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/2040-2392-4-45     Document Type: Article

References (72)

1. Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, United States, 2006. CfDCa P, MMWR Surveill Summ 2009 58 1 20
2. A public health collaboration for the surveillance of autism spectrum disorders. Rice CE, Baio J, Van Naarden Braun K, Doernberg N, Meaney FJ, Kirby RS, Paediatr Perinat Epidemiol 2007 21 179 190 10.1111/j.1365-3016.2007.00801.x 17302648
3. Autism spectrum disorders: a pediatric overview and update. Tchaconas A, Adesman A, Curr Opin Pediatr 2013 25 130 144 10.1097/MOP.0b013e32835c2b70 23274432
4. Genetics of autism: complex aetiology for a heterogeneous disorder. Folstein SE, Rosen-Sheidley B, Nat Rev Genet 2001 2 943 955 10.1038/35103559 11733747 (Pubitemid 33691091)
5. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, El-Fishawy P, Murtha RC, Choi M, Overton JD, Bjornson RD, Carriero NJ, Meyer KA, Bilguvar K, Mane SM, Sestan N, Lifton RP, Günel M, Roeder K, Geschwind DH, Devlin B, State MW, Nature 2012 485 237 241 10.1038/nature10945 22495306
6. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Jiang YH, Yuen RK, Jin X, Wang M, Chen N, Wu X, Ju J, Mei J, Shi Y, He M, Wang G, Liang J, Wang Z, Cao D, Carter MT, Chrysler C, Drmic IE, Howe JL, Lau L, Marshall CR, Merico D, Nalpathamkalam T, Thiruvahindrapuram B, Thompson A, Uddin M, Walker S, Luo J, Anagnostou E, Zwaigenbaum L, Ring RH, Wang J, Lajonchere C, Wang J, Shih A, Szatmari P, Yang H, Dawson G, Li Y, Scherer SW, Am J Hum Genet 2013 93 249 263 10.1016/j.ajhg.2013.06.012 23849776
7. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Buxbaum JD, Daly MJ, Devlin B, Lehner T, Roeder K, State MW, Neuron 2012 76 1052 1056 10.1016/j.neuron.2012.12.008 23259942
8. The genetic variability and commonality of neurodevelopmental disease. Coe BP, Girirajan S, Eichler EE, Am J Med Genet C: Semin Med Genet 2012 160C 118 129 10.1002/ajmg.c.31327 22499536
9. The ongoing dissection of the genetic architecture of autistic spectrum disorder. Gillis RF, Rouleau GA, Mol Autism 2011 2 12 10.1186/2040-2392-2-12 21740537
10. Mining and modeling human genetics for autism therapeutics. Smith DG, Ehlers MD, Curr Opin Neurobiol 2012 22 902 910 10.1016/j.conb.2012.03.004 22483267
11. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, Rea A, Guy M, Lin S, Cook EH, Chakravarti A, Am J Hum Genet 2008 82 160 164 10.1016/j.ajhg.2007.09.015 18179894 (Pubitemid 351726090)
12. Structural variation of chromosomes in autism spectrum disorder. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, Thiruvahindrapduram B, Fiebig A, Schreiber S, Friedman J, Ketelaars CE, Vos YJ, Ficicioglu C, Kirkpatrick S, Nicolson R, Sloman L, Summers A, Gibbons CA, Teebi A, Chitayat D, Weksberg R, Thompson A, Vardy C, Crosbie V, Luscombe S, Baatjes R, Zwaigenbaum L, Roberts W, Fernandez B, Szatmari P, Scherer SW, Am J Hum Genet 2008 82 477 488 10.1016/j.ajhg.2007.12.009 18252227
13. Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling. Tamada K, Tomonaga S, Hatanaka F, Nakai N, Takao K, Miyakawa T, Nakatani J, Takumi T, PLoS One 2010 5 15126 10.1371/journal.pone.0015126 21179543
14. A genome-wide linkage and association scan reveals novel loci for autism. Weiss LA, Arking DE, Daly MJ, Chakravarti A, Nature 2009 461 802 808 10.1038/nature08490 19812673
15. Childhood autism and associated comorbidities. Zafeiriou DI, Ververi A, Vargiami E, Brain Dev 2007 29 257 272 10.1016/j.braindev.2006.09.003 17084999 (Pubitemid 46483916)
16. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME, Science 2003 302 885 889 10.1126/science.1086446 14593183 (Pubitemid 37339632)
17. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE, Science 2003 302 890 893 10.1126/science.1090842 14593184 (Pubitemid 37339633)
18. SFARI Gene: an evolving database for the autism research community. Banerjee-Basu S, Packer A, Dis Model Mech 2010 3 133 135 10.1242/dmm.005439 20212079
19. Genetic advances in autism: heterogeneity and convergence on shared pathways. Bill BR, Geschwind DH, Curr Opin Genet Dev 2009 19 271 278 10.1016/j.gde.2009.04.004 19477629
20. Protein interactome reveals converging molecular pathways among autism disorders. Sakai Y, Shaw CA, Dawson BC, Dugas DV, Al-Mohtaseb Z, Hill DE, Zoghbi HY, Sci Transl Med 2011 3 86
21. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin CF, Stevens C, Wang LS, Makarov V, Polak P, Yoon S, Maguire J, Crawford EL, Campbell NG, Geller ET, Valladares O, Schafer C, Liu H, Zhao T, Cai G, Lihm J, Dannenfelser R, Jabado O, Peralta Z, Nagaswamy U, Muzny D, Reid JG, Newsham I, Wu Y, Lewis L, Han Y, Voight BF, Lim E, Rossin E, Kirby A, Flannick J, Fromer M, Shakir K, Fennell T, Garimella K, Banks E, Poplin R, Gabriel S, DePristo M, Wimbish JR, Boone BE, Levy SE, Betancur C, Sunyaev S, Boerwinkle E, Buxbaum JD, Cook EH Jr, Devlin B, Gibbs RA, Roeder K, Schellenberg GD, Sutcliffe JS, Daly MJ, Nature 2012 485 242 245 10.1038/nature11011 22495311
22. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE, Nature 2012 485 246 250 10.1038/nature10989 22495309
23. A synaptic trek to autism. Bourgeron T, Curr Opin Neurobiol 2009 19 231 234 10.1016/j.conb.2009.06.003 19545994
24. The neurobiology of autism. Pardo CA, Eberhart CG, Brain Pathol 2007 17 434 447 10.1111/j.1750-3639.2007.00102.x 17919129 (Pubitemid 47537607)
25. The genetic landscapes of autism spectrum disorders. Huguet G, Ey E, Bourgeron T, Annu Rev Genomics Hum Genet 2013 14 191 213 10.1146/annurev-genom- 091212-153431 23875794
26. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C, J Med Genet 2005 42 318 321 10.1136/jmg.2004.024646 15805158 (Pubitemid 40523954)
27. Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Fraser MM, Bayazitov IT, Zakharenko SS, Baker SJ, Neuroscience 2008 151 476 488 10.1016/j.neuroscience.2007.10.048 18082964
28. Pten knockdown in vivo increases excitatory drive onto dentate granule cells. Luikart BW, Schnell E, Washburn EK, Bensen AL, Tovar KR, Westbrook GL, J Neurosci 2011 31 4345 4354 10.1523/JNEUROSCI.0061-11.2011 21411674
29. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Rogé B, Héron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T, Nat Genet 2007 39 25 27 10.1038/ng1933 17173049 (Pubitemid 46026497)
30. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SF, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H, Nature 2009 459 569 573 10.1038/nature07953 19404257
31. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T, Nat Genet 2003 34 27 29 10.1038/ng1136 12669065 (Pubitemid 36548785)
32. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Flavell SW, Kim TK, Gray JM, Harmin DA, Hemberg M, Hong EJ, Markenscoff- Papadimitriou E, Bear DM, Greenberg ME, Neuron 2008 60 1022 1038 10.1016/j.neuron.2008.11.029 19109909
33. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME, Science 2006 311 1008 1012 10.1126/science.1122511 16484497 (Pubitemid 43271729)
34. Role of the PACAP-PAC1-DISC1 and PACAP-PAC1-stathmin1 systems in schizophrenia and bipolar disorder: novel treatment mechanisms? Katayama T, Hattori T, Yamada K, Matsuzaki S, Tohyama M, Pharmacogenomics 2009 10 1967 1978 10.2217/pgs.09.147 19958095
35. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, Leboyer M, Gillberg C, Bourgeron T, Trends Genet 2010 26 363 372 10.1016/j.tig.2010.05.007 20609491
36. Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Zhang SJ, Steijaert MN, Lau D, Schutz G, Delucinge-Vivier C, Descombes P, Bading H, Neuron 2007 53 549 562 10.1016/j.neuron.2007.01.025 17296556 (Pubitemid 46216756)
37. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Hagberg B, Aicardi J, Dias K, Ramos O, Ann Neurol 1983 14 471 479 10.1002/ana.410140412 6638958 (Pubitemid 13010048)
38. Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Hatton DD, Sideris J, Skinner M, Mankowski J, Bailey DB Jr, Roberts J, Mirrett P, Am J Med Genet A 2006 140A 1804 1813 10.1002/ajmg.a.31286 16700053 (Pubitemid 44330644)
39. Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with cowden syndrome, autistic disorder and epilepsy. Conti S, Condo M, Posar A, Mari F, Resta N, Renieri A, Neri I, Patrizi A, Parmeggiani A, J Child Neurol 2011 29 29
40. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP, Biostatistics 2003 4 249 264 10.1093/biostatistics/4.2.249 12925520
41. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Smyth GK, Stat Appl Genet Mol Biol 2004 3
42. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Benjamini Y, Hochberg Y, J Roy Statistical Soc 1995 57 289 300
43. Ontology-based meta-analysis of global collections of high-throughput public data. Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, Flynn J, Shekar M, Wang H, Park J, Cui W, Wall GD, Wisotzkey R, Alag S, Akhtari S, Ronaghi M, PLoS One 2010 5
44. Molecular signatures database (MSigDB) 3.0. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP, Bioinformatics 2011 27 1739 1740 10.1093/bioinformatics/btr260 21546393
45. GenSensor suite: a Web-based tool for the analysis of gene and protein interactions, pathways, and regulation. Gosink M, Khuri S, Valdes C, Jiang Z, Tsinoremas NF, Adv Bioinformatics 2011 2011 271563 22194743
46. A direct approach to false discovery rate. Store J, J R Stat Soc Ser B 2002 64 479 498 10.1111/1467-9868.00346
47. Causal Reasoning on Biological Networks: Interpreting Transcriptional Changes. Chindelevitch L, Ziemek D, Enayetallah A, Randhawa R, Sidders B, Brockel C, Huang E, In Bioinformatics 2012 28 1114 21 10.1093/bioinformatics/ bts090
48. Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platform. Enayetallah AE, Ziemek D, Leininger MT, Randhawa R, Yang J, Manion TB, Mather DE, Zavadoski WJ, Kuhn M, Treadway JL, des Etages SA, Gibbs EM, Greene N, Steppan CM, PLoS One 2011 6 27009 10.1371/journal.pone.0027009 22073239
49. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T, Genome Res 2003 13 2498 2504 10.1101/gr.1239303 14597658 (Pubitemid 37428274)
50. Copy number variation modifies expression time courses. Chaignat E, Yahya-Graison EA, Henrichsen CN, Chrast J, Schutz F, Pradervand S, Reymond A, Genome Res 2011 21 106 113 10.1101/gr.112748.110 21084671
51. Transcriptional neoteny in the human brain. Somel M, Franz H, Yan Z, Lorenc A, Guo S, Giger T, Kelso J, Nickel B, Dannemann M, Bahn S, Webster MJ, Weickert CS, Lachmann M, Pääbo S, Khaitovich P, Proc Natl Acad Sci USA 2009 106 5743 5748 10.1073/pnas.0900544106 19307592
52. Network activity-independent coordinated gene expression program for synapse assembly. Valor LM, Charlesworth P, Humphreys L, Anderson CN, Grant SG, Proc Natl Acad Sci USA 2007 104 4658 4663 10.1073/pnas.0609071104 17360580 (Pubitemid 47186281)
53. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Hollander MC, Blumenthal GM, Dennis PA, Nat Rev Cancer 2011 11 289 301 21430697
54. Association of the polymorphisms in the 5′-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. Ishihara H, Sasaoka T, Kagawa S, Murakami S, Fukui K, Kawagishi Y, Yamazaki K, Sato A, Iwata M, Urakaze M, Ishiki M, Wada T, Yaguchi S, Tsuneki H, Kimura I, Kobayashi M, FEBS Lett 2003 554 450 454 10.1016/S0014-5793(03)01225-0 14623110 (Pubitemid 37412530)
55. Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system. Ehlert EM, Eggers R, Niclou SP, Verhaagen J, BMC Neurosci 2010 11 20 10.1186/1471-2202-11-20 20167052
56. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). Persengiev SP, Zhu X, Green MR, Rna 2004 10 12 18 10.1261/rna5160904 14681580 (Pubitemid 38018731)
57. Autism and developmental abnormalities in children with perinatal cocaine exposure. Davis E, Fennoy I, Laraque D, Kanem N, Brown G, Mitchell J, J Natl Med Assoc 1992 84 315 319 1380564
58. Context-specific modulation of cocaine-induced locomotor sensitization and ERK and CREB phosphorylation in the rat nucleus accumbens. Marin MT, Berkow A, Golden SA, Koya E, Planeta CS, Hope BT, Eur J Neurosci 2009 30 1931 1940 10.1111/j.1460-9568.2009.06982.x 19912338
59. Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior. Tropea TF, Kosofsky BE, Rajadhyaksha AM, J Neurochem 2008 106 1780 1790 10.1111/j.1471-4159.2008.05518.x 18554320
60. Chronic cocaine self-administration modulates ERK1/2 and CREB responses to dopamine receptor agonists in striatal slices. Hoffmann HM, Nadal R, Vignes M, Ortiz J, Addict Biol 2011 17 565 575 21812869
61. Fetal exposure to teratogens: evidence of genes involved in autism. Dufour-Rainfray D, Vourc'h P, Tourlet S, Guilloteau D, Chalon S, Andres CR, Neurosci Biobehav Rev 2011 35 1254 1265 10.1016/j.neubiorev.2010.12.013 21195109
62. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G, J Neurosci 2004 24 6590 6599 10.1523/JNEUROSCI.5747- 03.2004 15269271 (Pubitemid 38971708)
63. Association of upregulated Ras/Raf/ERK1/2 signaling with autism. Zou H, Yu Y, Sheikh AM, Malik M, Yang K, Wen G, Chadman KK, Brown WT, Li X, Genes Brain Behav 2011 10 615 624 10.1111/j.1601-183X.2011.00702.x 21595826
64. Upregulation of Ras/Raf/ERK1/2 signaling and ERK5 in the brain of autistic subjects. Yang K, Sheikh AM, Malik M, Wen G, Zou H, Brown WT, Li X, Genes Brain Behav 2011 10 834 43 10.1111/j.1601-183X.2011.00723.x 21848643
65. Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubule-associated protein 2 kinase. Boulton TG, Gregory JS, Cobb MH, Biochemistry 1991 30 278 286 10.1021/bi00215a038 1846291
66. Embryonic MAP2 lacks the cross-linking sidearm sequences and dendritic targeting signal of adult MAP2. Papandrikopoulou A, Doll T, Tucker RP, Garner CC, Matus A, Nature 1989 340 650 652 10.1038/340650a0 2770869 (Pubitemid 19202576)
67. In vitro phosphorylation of microtubule-associated protein 2: differential effects of cyclic AMP analogues. Richter-Landsberg C, Jastorff B, J Neurochem 1985 45 1218 1222 10.1111/j.1471-4159.1985.tb05545.x 2993522 (Pubitemid 16252063)
68. Intracellular control of developmental and regenerative axon growth. Zhou FQ, Snider WD, Philos Trans R Soc Lond B Biol Sci 2006 361 1575 1592 10.1098/rstb.2006.1882 16939976 (Pubitemid 44450212)
69. Signaling mechanisms underlying reversible, activity-dependent dendrite formation. Vaillant AR, Zanassi P, Walsh GS, Aumont A, Alonso A, Miller FD, Neuron 2002 34 985 998 10.1016/S0896-6273(02)00717-1 12086645 (Pubitemid 34722287)
70. Dendritic spine plasticity: new regulatory roles of dynamic microtubules. Hoogenraad CC, Akhmanova A, Neuroscientist 2010 16 650 661 10.1177/ 1073858410386357 21239729
71. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP, Pages G, Valverde O, Marowsky A, Porrazzo A, Orban PC, Maldonado R, Ehrengruber MU, Cestari V, Lipp HP, Chapman PF, Pouysségur J, Brambilla R, Neuron 2002 34 807 820 10.1016/S0896-6273(02)00716-X 12062026 (Pubitemid 34628742)
72. Specific functions for ERK/MAPK signaling during PNS development. Newbern JM, Li X, Shoemaker SE, Zhou J, Zhong J, Wu Y, Bonder D, Hollenback S, Coppola G, Geschwind DH, Landreth GE, Snider WD, Neuron 2011 69 91 105 10.1016/j.neuron.2010.12.003 21220101